92 related articles for article (PubMed ID: 3220112)
21. Cholecystokinin-induced release of dopamine in the nucleus accumbens of the spontaneously hypertensive rat.
Kirouac GJ; Ganguly PK
Brain Res; 1995 Aug; 689(2):245-53. PubMed ID: 7583328
[TBL] [Abstract][Full Text] [Related]
22. Does cholecystokinin potentiate dopamine action in the nucleus accumbens?
Wang RY; Hu XT
Brain Res; 1986 Aug; 380(2):363-7. PubMed ID: 3756487
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiological evidence of modulatory interaction between dopamine and cholecystokinin in the nucleus accumbens.
Yim CC; Mogenson GJ
Brain Res; 1991 Feb; 541(1):12-20. PubMed ID: 2029612
[TBL] [Abstract][Full Text] [Related]
24. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.
Crawley JN; Hommer DW; Skirboll LR
Brain Res; 1985 Jun; 335(2):337-41. PubMed ID: 4005562
[TBL] [Abstract][Full Text] [Related]
25. Cholecystokinin modulates mesolimbic dopaminergic influences on male rat copulatory behavior.
Markowski VP; Hull EM
Brain Res; 1995 Nov; 699(2):266-74. PubMed ID: 8616630
[TBL] [Abstract][Full Text] [Related]
26. Decreased haloperidol-induced potentiation of zif268 mRNA expression in the nucleus accumbens shell and the dorsal lateral striatum of rats lacking cholecystokinin-A receptors.
Shilling PD; Feifel D
Synapse; 2002 Feb; 43(2):134-8. PubMed ID: 11754493
[TBL] [Abstract][Full Text] [Related]
27. Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro.
Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
J Physiol; 2004 Feb; 555(Pt 1):71-84. PubMed ID: 14673185
[TBL] [Abstract][Full Text] [Related]
28. Cholecystokinin inhibits evoked inhibitory postsynaptic currents in the rat nucleus accumbens indirectly through gamma-aminobutyric acid and gamma-aminobutyric acid type B receptors.
Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
J Neurosci Res; 2005 Feb; 79(3):412-20. PubMed ID: 15605383
[TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.
Pu SF; Zhuang HX; Han JS
Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614
[TBL] [Abstract][Full Text] [Related]
30. The effects of cholecystokinin (CCK-8) on dopamine-containing nerve terminals in the caudate nucleus and nucleus accumbens of the anesthetized rat: an in vivo electrochemical study.
Gerhardt GA; Friedemann M; Brodie MS; Vickroy TW; Gratton AP; Hoffer BJ; Rose GM
Brain Res; 1989 Oct; 499(1):157-63. PubMed ID: 2804664
[TBL] [Abstract][Full Text] [Related]
31. Overflow of dopamine and cholecystokinin in rat nucleus accumbens in response to acute drug administration.
Hamilton ME; Redondo JL; Freeman AS
Synapse; 2000 Dec; 38(3):238-42. PubMed ID: 11020226
[TBL] [Abstract][Full Text] [Related]
32. Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264.
Dauge V; Bohme GA; Crawley JN; Durieux C; Stutzmann JM; Feger J; Blanchard JC; Roques BP
Synapse; 1990; 6(1):73-80. PubMed ID: 2399491
[TBL] [Abstract][Full Text] [Related]
33. Electrophysiological effects of cholecystokinin: central dopaminergic systems.
Wang RY; White FJ
Prog Clin Biol Res; 1985; 192():95-103. PubMed ID: 4080721
[TBL] [Abstract][Full Text] [Related]
34. Cholecystokinin-dopamine receptor interactions as studied with cholecystokinin receptor antagonists.
Murphy RB
Prog Clin Biol Res; 1985; 192():105-13. PubMed ID: 3001746
[TBL] [Abstract][Full Text] [Related]
35. Cholecystokinin potentiation of dopamine-mediated behaviors in the nucleus accumbens.
Crawley JN
Ann N Y Acad Sci; 1985; 448():283-92. PubMed ID: 3861122
[No Abstract] [Full Text] [Related]
36. CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons.
Rasmussen K
Ann N Y Acad Sci; 1994 Mar; 713():300-11. PubMed ID: 8185172
[No Abstract] [Full Text] [Related]
37. [125I][D-Tyr25,Nle28,31]CCK-(25-33): a convenient new aminopeptidase resistant cholecystokinin analogue for radioligand binding and autoradiography.
Carlberg M; Beart PM; Jarrott B
Eur J Pharmacol; 1990 Nov; 191(1):107-10. PubMed ID: 2092997
[TBL] [Abstract][Full Text] [Related]
38. Effects of administration of cholecystokinin into the VTA on DA overflow in nucleus accumbens and amygdala of freely moving rats.
Hamilton ME; Freeman AS
Brain Res; 1995 Aug; 688(1-2):134-42. PubMed ID: 8542299
[TBL] [Abstract][Full Text] [Related]
39. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
Vaccarino FJ; Rankin J
Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
[TBL] [Abstract][Full Text] [Related]
40. Neurotensin and cholecystokinin octapeptide control synergistically dopamine release and dopamine D2 receptor affinity in rat neostriatum.
Tanganelli S; Li XM; Ferraro L; Von Euler G; O'Connor WT; Bianchi C; Beani L; Fuxe K
Eur J Pharmacol; 1993 Jan; 230(2):159-66. PubMed ID: 8422898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
